Ibuprofen & Paracetamol Galpharm Healthcare (Ibuprofen, Paracetamol)

Ibuprofen blocks cyclooxygenase (COX‑1 and COX‑2) enzymes, which reduces the production of prostaglandins that mediate pain, fever, and inflammation. In the combination, it contributes peripheral analgesia and anti‑inflammatory activity, complementing paracetamol’s central analgesic and antipyretic actions.

The appropriate dose is determined by the prescribing healthcare professional based on the individual’s age, weight, clinical condition and other medications. The prescriber will specify the exact amount and frequency in accordance with local guidelines and product labeling.

Safety in pregnancy and lactation should be evaluated by a qualified healthcare provider. Ibuprofen may pose risks in the third trimester, while paracetamol is generally considered compatible with short‑term use. Women who are pregnant or nursing should seek professional advice before using this combination.

To place an order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

The ibuprofen‑paracetamol combination offers dual mechanisms: peripheral COX inhibition from ibuprofen and central COX modulation from paracetamol. This can provide broader pain relief and fever control than either agent alone, often allowing lower individual doses and potentially reducing the risk of dose‑related side effects.

Store the tablets at ambient temperature below 25 °C. Keep them in the original packaging to protect from moisture and light. Do not store in areas with high humidity or extreme heat, and keep out of reach of children.

The product is taken orally, usually with a full glass of water. It may be taken with or without food, although taking it with food can reduce gastrointestinal discomfort. Follow the dosing instructions provided by the prescriber or the product label.

Serious risks include severe allergic reactions (anaphylaxis), gastrointestinal bleeding or ulcer perforation, acute liver injury, and acute kidney impairment. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, severe abdominal pain, dark urine, jaundice, or sudden loss of kidney function.

Individuals with known hypersensitivity to ibuprofen, paracetamol, or any excipients should avoid the product. It is also contraindicated in patients with severe renal or hepatic impairment, active gastrointestinal ulcer disease, and in the third trimester of pregnancy unless specifically advised by a healthcare professional.